Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

2(25%)

Results Posted

150%(3 trials)

Terminated

1(13%)

Phase Distribution

Ph not_applicable

25%

Ph phase_1

38%

Ph phase_2

38%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 1Safety & dosage

3(37.5%)

Phase 2Efficacy & side effects

3(37.5%)

N/ANon-phased studies

2(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(2)

Terminated(2)

Other(2)

Detailed Status

Completed2

Recruiting2

unknown2

Terminated1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 2

Trials by Phase

Phase 13 (37.5%)

Phase 23 (37.5%)

N/A2 (25.0%)

Trials by Status

completed225%

recruiting225%

terminated113%

withdrawn113%

unknown225%

Recent Activity

2 active trials

Showing 5 of 8

recruitingphase_1

Clenbuterol to Target DUX4 in FSHD

NCT06721299

recruitingphase_2

A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy

NCT06169046

unknownnot_applicable

Muscle Memory After Treatment With Anabolic Substance Clenbuterol and Resistance Training in Humans

NCT05692856

completedphase_2

Clenbuterol on Motor Function in Individuals With Amyotrophic Lateral Sclerosis

NCT04245709

withdrawnphase_2

Phase II Clinical Trial of Clenbuterol in Adult Patients With Pompe Disease

NCT04094948

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT06721299Phase 1

Clenbuterol to Target DUX4 in FSHD

Recruiting

NCT06169046Phase 2

A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy

Recruiting

NCT05692856Not Applicable

Muscle Memory After Treatment With Anabolic Substance Clenbuterol and Resistance Training in Humans

Unknown

NCT04245709Phase 2

Clenbuterol on Motor Function in Individuals With Amyotrophic Lateral Sclerosis

Completed

NCT04094948Phase 2

Phase II Clinical Trial of Clenbuterol in Adult Patients With Pompe Disease

Withdrawn

NCT01942590Phase 1

Safety and Efficacy of Clenbuterol in Individuals With Late-onset Pompe Disease and Receiving Enzyme Replacement Therapy

Completed

NCT00585546Phase 1

Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure

Terminated

NCT02557581Not Applicable

cAMP Signaling and Muscle Adaptations

Unknown

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8